Scan role in diagnosing acute appendicitis

Acute appendicitis is one of the commonest surgical diseases. It can rapidly progress to severe complications, like perforation and peritonitis. Consequently, surgeons often prefer to operate as soon as there is, clinically, a probable diagnosis, even if such a decision results in the ablation of up to 30% of normal appendixes. Many diagnostic methods have been proposed with the aim of decreasing the number of appendectomies in patients without appendicitis: ultrasonography, computed tomography, magnetic resonance imaging, laparoscopy. In particular, ultrasonography has the advantage of being less expensive, widely available, and non-invasive; furthermore, it has demonstrated a diagnostic accuracy of 70-95%. However, its use needs further evaluation with respect to the best way to integrate it with clinical and laboratory data, in order to correctly identify a patient with suspected acute appendicitis. The aim of our study is to show our experience with ultrasonographic diagnosis of acute appendicitis, acquired by surgeons with specific sonographic expertise

Implementation of the ERAS (Enhanced Recovery after Surgery) protocol for colorectal cancer surgery in the Piemonte Region with an Audit and Feedback approach: Study protocol for a stepped wedge cluster randomised trial: A study of the EASY-NET project

Introduction The ERAS protocol (Enhanced Recovery After Surgery) is a multimodal pathway aimed to reduce surgical stress and to allow a rapid postoperative recovery. Application of the ERAS protocol to colorectal cancer surgery has been limited to a minority of hospitals in Italy. To promote the systematic adoption of ERAS in the entire regional hospital network in Piemonte an Audit and Feedback approach (A&F) has been adopted together with a cluster randomised trial to estimate the true impact of the protocol on a large, unselected population. Methods A multicentre stepped wedge cluster randomised trial is designed for comparison between standard perioperative management and the management according to the ERAS protocol. The primary outcome is the length of hospital stay (LOS). Secondary outcomes are: incidence of postoperative complications, time to patients' recovery, control of pain and patients' satisfaction. With an A&F approach the adherence to the ERAS items is monitored through a dedicated area in the study web site. The study includes 28 surgical centres, stratified by activity volume and randomly divided into four groups. Each group is randomly assigned to a different activation period of the ERAS protocol. There are four activation periods, one every 3 months. However, the planned calendar and the total duration of the study have been extended by 6 months due to the COVID-19 pandemic. The expected sample size of about 2200 patients has a high statistical power (98%) to detect a reduction of LOS of 1 day and to estimate clinically meaningful changes in the other endpoints. Ethics and dissemination The study protocol has been approved by the Ethical Committee of the coordinating centre and by all participating centres. Study results will be timely circulated within the hospital network and published in peer-reviewed journals. Trial registration number NCT04037787